21 Recruiting Studies Using Mfolfirinox
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Mfolfirinox
A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer
📍 Virginia Mason Medical Center — Seattle, Washington
Metastatic Pancreatic Adenocarcinoma
View Study & Checklist ➔Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma
📍 Yale University School of Medicine — New Haven, Connecticut
Pancreatic Cancer
View Study & Checklist ➔Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
Pancreatic Cancer
View Study & Checklist ➔A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 UCLA Healthcare Hematology-Oncology — Santa Monica, California
Solid Tumors
View Study & Checklist ➔Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
📍 University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery
📍 Juravinski Hospital — Hamilton, Ontario
Pancreatic Adenocarcinoma
View Study & Checklist ➔BBO-11818 in Adult Subjects With KRAS Mutant Cancer
📍 The Angeles Clinic and Research Institute - West Los Angeles Office — Los Angeles, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
Metastatic Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Pancreatic Cancer
View Study & Checklist ➔Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
📍 Stanford University — San Francisco, California
Pancreatic Cancer
View Study & Checklist ➔Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
📍 Ironwood Cancer and Research Centers — Chandler, Arizona
Colorectal Cancer
View Study & Checklist ➔PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
📍 HonorHealth Medical Group — Scottsdale, Arizona
Pancreatic Cancer
View Study & Checklist ➔A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
📍 Research Site — Orlando, Florida
Cancer
View Study & Checklist ➔A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Phase 2 Study
View Study & Checklist ➔M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
Advanced Solid Tumor
View Study & Checklist ➔A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
📍 Karmanos Cancer Center — Detroit, Michigan
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
📍 Mayo Clinic Hospital — Phoenix, Arizona
Solid Tumors
View Study & Checklist ➔Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
📍 Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina
Pancreas Adenocarcinoma
View Study & Checklist ➔Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
📍 Mayo Clinic Scottsdale — Scottsdale, Arizona
PDAC
View Study & Checklist ➔A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Adenocarcinoma, Pancreatic Ductal
View Study & Checklist ➔Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Stage III Colon Cancer
View Study & Checklist ➔